Cereton, 400 mg capsules 28 pcs

Pharmacodynamics

Cereton is a nootropic. It is a central cholinostimulant containing 40.5% metabolically protected choline. Metabolically protected promotes the release of choline in the brain.

Provides synthesis of acetylcholine and phosphatidylcholine in neuronal membranes, improves blood flow and enhances metabolic processes in the central nervous system, activates the reticular formation.

increases linear velocity of blood flow on the side of the traumatic brain injury, promotes normalization of spatiotemporal characteristics: spontaneous bioelectrical activity of the brain, regression of focal neurological symptoms and restoration of consciousness; has a positive effect on the cognitive and behavioral responses of patients with cerebral vascular disease (discirculatory encephalopathy and residual effects of cerebral circulatory disorders).

It has preventive and corrective effect on pathogenetic factors of involutional psychoorganic syndrome, changes phospholipid composition of neuron membranes: participates in the synthesis of phosphatidylcholine (membrane phospholipid) and improves neuronal membrane plasticity. Stimulates dose-dependent release of acetylcholine under physiological conditions, improves synaptic transmission and receptor function. It has no effect on the reproductive cycle and has no teratogenic and mutagenic effect.

Pharmacokinetics

. Easily penetrates the blood-brain barrier, 85% is excreted by the lungs as carbon dioxide, the remaining amount (15%) is excreted by the kidneys and through the intestine.

Indications

Active ingredient

Composition

1 capsule contains:

the active ingredient:

choline alphoscerate in terms of 100% substance – 400 mg;

excipients:

Glycerol,

Purified water;

Capsule composition:

gelatin,

sorbitol,

glycerol,

methyl parahydroxybenzoate,

propyl parahydroxybenzoate,

Titanium dioxide,

Iron oxide yellow dye,

Purified water.

How to take, the dosage

In the recovery period of craniocerebral trauma, ischemic or hemorrhagic stroke, Cereton is prescribed 800 mg in the morning and 400 mg during the day for 6 months.

In chronic cerebrovascular insufficiency and dementia syndromes, Cereton is prescribed 400 mg (1 capsule) 3 times daily, preferably after meals, for 3-6 months.

Special Instructions

Cereton has no effect on the speed of psychomotor reactions.

Contraindications

Side effects

Nausea may occur (mainly as a consequence of dopaminergic activation), in which case the drug dose should be reduced.

Allergic reactions.

Overdose

Nausea may be noted.

Treatment: symptomatic therapy.

Pregnancy use

The use of the drug Cereton during pregnancy and while breastfeeding is contraindicated.

Breastfeeding should be stopped during treatment with Cereton.

Similarities